序列CRISPR查显示,部分NatB抑制是一种减轻人类神经元中α-synuclein水平的策略
Saranya Santhosh Kumar1,2, Nima N Naseri2,3, Sarshan R Pather2,4
1Department of Bioengineering, School of Engineering and Applied Sciences, University of Pennsylvania, Philadelphia, PA, USA.
Science advances
|February 9, 2024
概括
研究人员确定了α-synuclein (αSyn) 蛋白的关键调节者,这对帕金森病至关重要. 通过NatB酶向氨基末端乙化提供了一种潜在的治疗策略,以降低αSyn水平.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 生物化学 生物化学
背景情况:
- 阿尔法同核素 (αSyn) 蛋白水平与帕金森病 (PD) 的风险和严重程度有关.
- 降低αSyn是神经退行性疾病的一个有前途的治疗策略.
研究的目的:
- 系统地绘制控制内源性αSyn.监管网络的地图.
- 确定新型治疗点,降低同核蛋白病变中的αSyn.
主要方法:
- 在SNCA标记细胞和iNeurons中使用了顺序的CRISPR-knockout和CRISPR干扰屏幕.
- 研究了氨基末端乙化和蛋白质体降解途径的作用.
- 评估了二甲氨基酶2抑制对αSyn水平的影响.
主要成果:
- 确定了氨基末端乙转移酶B (NatB) 酶作为内源性αSyn.的强有力的修饰剂.
- 证明了氨基末端乙化保护细胞质αSyn免受通过Ube2w的蛋白质体降解.
- 表明抑制二甲氨基酶2可降低i神经元中的αSyn与SNCA三倍化.
结论:
- 揭示了调节内源性αSyn.的基因网络.
- 非乙化αSyn降解的阐明机制.
- 突出了在同核蛋白病变中减少αSyn的潜在治疗途径.
更多相关视频
12:01Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
Published on: May 30, 2015
10.7K
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
9.6K
相关概念视频
CRISPR
46.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
46.4K
Neural Regulation
34.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.8K
